# COVID-19 autumn 2022/23 booster regression discontinuity analysis

Link to preprint: [Schaffer et al. Effect of the 2022 COVID-19 booster vaccination campaign in 50 year olds in England: regression discontinuity analysis in OpenSAFELY. medrxiv 2023 doi: 10.1101/2023.09.07.23295194](https://www.medrxiv.org/content/10.1101/2023.09.07.23295194v1)

[View on OpenSAFELY](https://jobs.opensafely.org/repo/https%253A%252F%252Fgithub.com%252Fopensafely%252Fvax-fourth-dose-RD)

Details of the purpose and any published outputs from this project can be found at the link above.

This study estimates the effectiveness of the second booster (fourth dose) COVID-19 vaccine using a regression discontinuity design. 

The contents of this repository MUST NOT be considered an accurate or valid representation of the study or its purpose. 
This repository may reflect an incomplete or incorrect analysis with no further ongoing work.
The content has ONLY been made public to support the OpenSAFELY [open science and transparency principles](https://www.opensafely.org/about/#contributing-to-best-practice-around-open-science) and to support the sharing of re-usable code for other subsequent users.
No clinical, policy or safety conclusions must be drawn from the contents of this repository.

# About the OpenSAFELY framework

The OpenSAFELY framework is a Trusted Research Environment (TRE) for electronic
health records research in the NHS, with a focus on public accountability and
research quality.

Read more at [OpenSAFELY.org](https://opensafely.org).

## Licences

As standard, research projects have a MIT license. 
